MMPs may also regulate cancer-related angiogenesis, both positively through their ability to mobilize or activate pro-angiogenic factors [35], and negatively via generation of angiogenesis inhibitors, such as angiostatin and endostatin, cleaved from large protein precursors [36]. The gene discussed is COL18A1; the disease is cancer.